Spokane WA 前列腺癌临床试验
7项针对 前列腺癌的研究正在 Spokane及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-North Spokane, Spokane
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 105, Spokane
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Spokane Urology ( Site 0035), Spokane
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
招募中3 期
- Research Site, Spokane
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
招募中1/2 期
- Summit Cancer Centers, Spokane
其他城市的 前列腺癌试验
- New York City, NY101 项研究
- Houston, TX73 项研究
- Los Angeles, CA64 项研究
- Boston, MA56 项研究
- Seattle, WA45 项研究
- St. Louis, MO45 项研究
- Chicago, IL45 项研究
- Baltimore, MD45 项研究
- San Francisco, CA44 项研究
- Philadelphia, PA41 项研究
- Nashville, TN40 项研究
- Washington, DC39 项研究
Spokane的其他研究
- 非小细胞肺癌10 项研究
- 乳腺癌8 项研究
- 卵巢癌8 项研究
- 结直肠癌8 项研究
- 帕金森病8 项研究
- 癌症（所有类型）6 项研究
- 头颈鳞状细胞癌6 项研究
- 慢性淋巴细胞白血病6 项研究
- 黑色素瘤5 项研究
- 三阴性乳腺癌5 项研究
- 地图样萎缩5 项研究
- 黄斑变性5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。